Bukofzer Stan 4
4 · Assertio Therapeutics, Inc · Filed Feb 12, 2020
Insider Transaction Report
Form 4
Bukofzer Stan
Chief Medical Officer & SVP***
Transactions
- Exercise/Conversion
Common Stock
2020-02-12+27,588→ 54,524 total - Tax Payment
Common Stock
2020-02-12$1.35/sh−9,545$12,886→ 44,979 total - Exercise/Conversion
Restricted Stock Units
2020-02-12−27,588→ 55,175 totalExp: 2022-02-12→ Common Stock (27,588 underlying)
Footnotes (4)
- [F1]Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
- [F3]One-third of these restricted stock units are scheduled to vest on each of February 12, 2020, 2021 and 2022.
- [F4]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.